X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Q: What does CUSIP 98420X103 represent in this 13F holders report?

CUSIP 98420X103 is the security identifier for XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share in Q2 2020?

54 institutional investors reported XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 98420X103

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 7,938,059
Total 13F shares: 10,703,549
Share change: -212,951
Total reported value: $99,748,639
Price per share: $9.32
Number of holders: 54
Value change: -$2,349,709
Number of buys: 32
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 98420X103?
CUSIP 98420X103 identifies XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 98420X103:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bain Capital Life Sciences Investors, LLC	13F	Company	21%	1,648,485	$16,485,000	—	31 Mar 2020	13F
BVF INC/IL	13F	Company	15%	1,171,728	$11,717,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	14%	1,086,493	$10,865,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	11%	875,549	$8,755,000	—	31 Mar 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	11%	873,215	$8,732,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	9.3%	739,048	$7,391,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	8.8%	697,800	$6,978,000	—	31 Mar 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	7.6%	602,274	$6,023,000	—	31 Mar 2020	13F
AXA S.A.	13F	Company	6.3%	502,163	$5,022,000	—	31 Mar 2020	13F
Cormorant Asset Management, LP	13F	Company	4.3%	341,618	$3,416,000	—	31 Mar 2020	13F
New Leaf Venture Partners, L.L.C.	13F	Company	4.2%	335,000	$3,350,000	—	31 Mar 2020	13F
NEA Management Company, LLC	13F	Company	4.2%	333,333	$3,333,000	—	31 Mar 2020	13F
Polaris Venture Management Co. V, L.L.C.	13F	Company	3.9%	311,492	$3,115,000	—	31 Mar 2020	13F
SV Health Investors, LLC	13F	Company	3.9%	311,490	$3,115,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	3.5%	274,955	$2,750,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.6%	209,419	$2,094,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	2.3%	183,574	$1,836,000	—	31 Mar 2020	13F
Alyeska Investment Group, L.P.	13F	Company	2.2%	176,902	$1,769,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.9%	153,202	$1,532,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.68%	53,844	$538,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.55%	43,864	$439,000	—	31 Mar 2020	13F
ClariVest Asset Management LLC	13F	Company	0.53%	41,900	$419,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.5%	39,328	$394,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.49%	38,931	$389,000	—	31 Mar 2020	13F
Bleichroeder LP	13F	Company	0.45%	35,730	$357,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.3%	24,136	$242,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.3%	23,445	$234,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.21%	16,546	$165,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	14,150	$142,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.15%	11,602	$116,000	—	31 Mar 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.14%	11,324	$113,000	—	31 Mar 2020	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.13%	10,350	$104,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.12%	9,283	$93,000	—	31 Mar 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.12%	9,131	$91,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	6,161	$61,000	—	31 Mar 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.08%	6,129	$61,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	5,577	$56,000	—	31 Mar 2020	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.06%	4,652	$46,520	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.05%	4,201	$42,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.05%	4,054	$41,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.05%	3,792	$38,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0.04%	3,144	$31,000	—	31 Mar 2020	13F
STRS OHIO	13F	Company	0.04%	3,100	$31,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.03%	2,346	$23,000	—	31 Mar 2020	13F
Legal & General Group Plc	13F	Company	0.03%	2,372	$21,000	—	31 Mar 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.03%	2,028	$20,000	—	31 Mar 2020	13F
Marshall Wace North America L.P.	13F	Company	0.02%	1,897	$19,000	—	31 Mar 2020	13F
Ameritas Investment Partners, Inc.	13F	Company	0.01%	987	$10,000	—	31 Mar 2020	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0.01%	475	$5,000	—	31 Mar 2020	13F
ROYAL BANK OF CANADA	13F	Company	0%	70	$1,000	—	31 Mar 2020	13F

Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q2 2020

As of 30 Jun 2020, X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,703,549 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, ORBIMED ADVISORS LLC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, SPHERA FUNDS MANAGEMENT LTD., RA CAPITAL MANAGEMENT, L.P., AXA, and STATE STREET CORP. This page lists 54 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.